Literature DB >> 15712198

Recurrence of Fabry disease as a result of paternal germline mosaicism for alpha-galactosidase a gene mutation.

Robert Dobrovolný1, Lenka Dvoráková, Jana Ledvinová, Sudheera Magage, Jan Bultas, Jean C Lubanda, Helena Poupetová, Milan Elleder, Debora Karetová, Martin Hrebícek.   

Abstract

We present two sisters with a severe form of Fabry disease, who both carry the same mutation in the alpha-galactosidase A (alpha-gal A) gene (Q330X). Each of the sisters developed renal failure in the third decade of life; the older sibling underwent renal transplantation at 40 years of age. The severe phenotype of the siblings correlates with results of the X-inactivation study: examination of methylation status in human androgene receptor (HUMARA) gene suggests preferential inactivation of the wild-type allele in both patients. Patients' parents had no symptoms of Fabry disease and were tested negative for the mutation Q330X in DNA isolated from peripheral leukocytes, mouth wash cells, and urinary sediment cells. Genotype analysis using DXS7424 marker showed paternal origin of the mutation. The father's sperm was then tested for presence of the mutation to examine the possibility of the germline mosaicism. Both mutant and wild-type alleles were found in DNA isolated from father's sperm. The apparent explanation of these findings is germline mosaicism due to mutation event during the embryonic development of sperm producing cells (spermatogonia). This is the first case of germline mosaicism in Fabry disease reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15712198     DOI: 10.1002/ajmg.a.30533

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Fabry or not Fabry--a question of ascertainment.

Authors:  Gunnar Houge; Camilla Tøndel; Oyvind Kaarbøe; Asle Hirth; Leif Bostad; Einar Svarstad
Journal:  Eur J Hum Genet       Date:  2011-05-18       Impact factor: 4.246

2.  Maternal germline mosaicism in Fabry disease.

Authors:  Luigi Pianese; Antonio Fortunato; Serena Silvestri; Francesco G Solano; Alberto Burlina; Alessandro P Burlina; Michele Ragno
Journal:  Neurol Sci       Date:  2019-02-14       Impact factor: 3.307

3.  Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population.

Authors:  Robert Dobrovolny; Lenka Dvorakova; Jana Ledvinova; Sudheera Magage; Jan Bultas; Jean C Lubanda; Milan Elleder; Debora Karetova; Marketa Pavlikova; Martin Hrebicek
Journal:  J Mol Med (Berl)       Date:  2005-04-02       Impact factor: 4.599

Review 4.  Fabry's disease: an example of cardiorenal syndrome type 5.

Authors:  Aashish Sharma; Marco Sartori; Jose J Zaragoza; Gianluca Villa; Renhua Lu; Elena Faggiana; Alessandra Brocca; Luca Di Lullo; Sandro Feriozzi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

Review 5.  The benefits and challenges of family genetic testing in rare genetic diseases-lessons from Fabry disease.

Authors:  Dominique P Germain; Sergey Moiseev; Fernando Suárez-Obando; Faisal Al Ismaili; Huda Al Khawaja; Gheona Altarescu; Fellype C Barreto; Farid Haddoum; Fatemeh Hadipour; Irina Maksimova; Mirelle Kramis; Sheela Nampoothiri; Khanh Ngoc Nguyen; Dau-Ming Niu; Juan Politei; Long-Sun Ro; Dung Vu Chi; Nan Chen; Sergey Kutsev
Journal:  Mol Genet Genomic Med       Date:  2021-04-09       Impact factor: 2.183

Review 6.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

Review 7.  Sperm mosaicism: implications for genomic diversity and disease.

Authors:  Martin W Breuss; Xiaoxu Yang; Joseph G Gleeson
Journal:  Trends Genet       Date:  2021-06-19       Impact factor: 11.821

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.